𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vascular Endothelial Growth Factor, Its Receptor KDR/Flk-1, and Pituitary Tumor Transforming Gene in Pituitary Tumors

✍ Scribed by McCabe, C. J.; Boelaert, K.; Tannahill, L. A.; Heaney, A. P.; Stratford, A. L.; Khaira, J. S.; Hussain, S.; Sheppard, M. C.; Franklyn, J. A.; Gittoes, N. J. L.

Book ID
121659272
Publisher
Endocrine Society
Year
2002
Tongue
English
Weight
259 KB
Volume
87
Category
Article
ISSN
0021-972X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

KDR/Flk-1 is a major regulator of vascul
KDR/Flk-1 is a major regulator of vascular endothelial growth factor–induced tumor development and angiogenesis in murine hepatocellular carcinoma cells
✍ Hitoshi Yoshiji; Shigeki Kuriyama; Daniel J. Hicklin; James Huber; Junichi Yoshi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB 👁 1 views

Vascular endothelial growth factor (VEGF), which is one of the most potent angiogenic factors, has been shown to play a pivotal role in tumor angiogenesis, including hepatocellular carcinoma (HCC). The effects of VEGF are mediated mainly through two distinct receptors, flt-1 and KDR/ Flk-1. It has b

Emodin inhibits vascular endothelial gro
Emodin inhibits vascular endothelial growth factor-A-induced angiogenesis by blocking receptor-2 (KDR/Flk-1) phosphorylation
✍ Hee-Jin Kwak; Myung-Jin Park; Chang-Min Park; Sang-Ik Moon; Doo-Hyun Yoo; Hyung- 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 911 KB

## Abstract Emodin (1,3,8‐trihydroxy‐6‐methylanthraquinone), an active component in the root and rhizome of __Rheum palmatum__, is a tyrosine kinase inhibitor with a number of biological activities, including antitumor effects. Here, we examine the effects of emodin on vascular endothelial growth f